Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer
Daiichi Sankyo
Daiichi Sankyo
Iovance Biotherapeutics, Inc.
CytoDyn, Inc.
Novartis
CG Oncology, Inc.
Children's Hospital of Philadelphia
Novartis
Janssen Research & Development, LLC
Gilead Sciences
Nuvalent Inc.
Cogent Biosciences, Inc.
SpringWorks Therapeutics, Inc.
Novartis
Regeneron Pharmaceuticals
Bayer
SpringWorks Therapeutics, Inc.
ImmunityBio, Inc.
ITM Solucin GmbH
Memorial Sloan Kettering Cancer Center
Novartis
Taiho Oncology, Inc.
Cogent Biosciences, Inc.
Aveni Foundation
Imaging Biometrics, LLC
Karyopharm Therapeutics Inc
Autolus Limited
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Milton S. Hershey Medical Center
Endevica Bio
Nuvalent Inc.
Janssen Scientific Affairs, LLC
AbbVie
USWM, LLC (dba US WorldMeds)
AbbVie
AbbVie
AbbVie
Takeda
AbbVie
xCures
Phoenix Children's Hospital
NanOlogy, LLC
NanOlogy, LLC